A ‘Magic Mushroom’ strategy for America’s opioid crisis
From a law enforcement perspective, hallucinogenics seem to hold promise for making society safer. From a policymaker perspective, they may improve society’s mental health. I’m not arguing that … any psychedelic should be distributed over the counter without a prescription.
But there should be no debate that the epidemic of opioids, and increasing incidences of chronic pain and PTSD require that we explore every promising treatment, including psychedelics. Ayahuasca, a bitter tea-like brew made from ingredients found in the Amazon basin. It also, reportedly has anti-addiction properties, though it now is under clinical trial in Brazil for treating depression. Johns Hopkins University has been studying therapeutic uses of psilocybin, found in “magic mushrooms” since 2000, and has found it causes “positive changes in attitudes, mood, altruism, behavior, and life satisfaction,” as well as aids in smoking cessation. A 2017 University of Alabama study found that people who had used a psychedelic drug even once were less likely to engage in violence or steal. A study published in The Lancet Psychiatry found that MDMA, popularly called “Ecstasy,” aids post-traumatic stress disorder (POTSDAM) patients by making them “more engaged in their therapy”.
Original Article (Crime Report):
New York’s Mayor Backs Supervised Injection Facilities to Reduce Opioid Deaths
Artwork Fair Use by: Public Domain